chartexchange

ARQT
Arcutis Biotherapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
28.25USD+2.615%(+0.72)858,231
Pre-marketNov 13, 2026 9:20:30 AM EST
27.86USD+1.199%(+0.33)
After-hoursNov 13, 2026 4:20:30 PM EST
28.00USD-0.885%(-0.25)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Westlake Village, CA, USA
Previous Close
$27.53
Beta
1.48
52-Week High
$34.80 2026-11-04
52-Week Low
$19.30 2026-05-19
SMA 50
$27.45
SMA 200
$25.37
Avg. Vol 10D
2.80M
Avg. Vol 30D
2.49M
Avg. Vol 90D
2.31M
Relative Vol
0.34
126.46M
110.17M
18,157,145
0.3300%
4,500,000
Feb 24, 2027 (101d)
ARQT Profile

arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 for the treatment of seborrheic dermatitis and scalp psoriasis; arq-252, a selective topical small molecule inhibitor of janus kinase type 1 for hand eczema and other inflammatory dermatoses; and arq-255, a topical formulation of arq-252 designed to reach deeper into the skin to the postulated site of inflammation in alopecia areata. the company was formerly known as arcutis, inc. and changed its name to arcutis biotherapeutics, inc. in october 2019. arcutis biotherapeutics, inc. was founded in 2016 and is headquartered in westlake village, california.

ARQT Performance
PeriodPriceDateChangeBeta
1W25.552026-11-06+10.57%0.833
1M26.092026-10-13+8.28%3.094
3M25.832026-08-13+9.37%2.471
6M21.692026-05-13+30.24%1.478
1Y22.862025-11-13+23.58%1.477
2Y10.472024-11-13+169.82%—
5Y21.192021-11-12+33.32%1.242
ARQT Stock Summary

Arcutis Biotherapeutics, Inc. Common Stock (NASDAQ:ARQT) stock price today is $28.25, and today's volume is 858,231. ARQT is up 2.615% today. The 30 day average volume is 2.49M. ARQT market cap is $3.57B with 126.46M shares outstanding.